ArriVent BioPharma (AVBP) Q1 2026 Earnings

5MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.9
-1.49
-1.08
-0.66

Details

Expected EPS
-0.84627
Actual EPS
-0.83964
Surprise EPS
0.01
Surprise Percent
+0.78%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.83964 per share for Q1 2026.

0 Comments

Share your thoughts